Publications

WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2.

Authors: JCJ Wilson, J Zhu, V Vinciauskaite, EG Lloyd, S Lam, A Hart, CG Goh, F Bou-...

E-pub date: 9 Oct 2025

Journal name: Nat Commun

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Authors: D Garsed, T Zwimpfer, S Fereday, A Pandey, D Ariyaratne, M Jayawardana, L T...

E-pub date: 3 Oct 2025

Journal name:

Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance.

Authors: L Wu, J Honing, A Wu, SS Kupfer, TM Bisseling, JM van Dieren, WK Tan, CYC L...

E-pub date: 1 Oct 2025

Journal name: Endoscopy

Artifacts in photoacoustic imaging: Origins and mitigations.

Authors: MT Rietberg, J Gröhl, TR Else, SE Bohndiek, S Manohar, BT Cox

E-pub date: 1 Oct 2025

Journal name: Photoacoustics

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Authors: TA Zwimpfer, S Fereday, A Pandey, D Ariyaratne, MW Jayawardana, L Twomey, C...

E-pub date: 22 Sep 2025

Journal name:

Coordinated protein modules define DNA damage responses to carboplatin at single-cell resolution in human ovarian carcinoma models.

Authors: JS Bedia, A Delgado-Gonzalez, Y-W Huang, VD Gonzalez, I-G Funingana, Z Rahi...

E-pub date: 16 Sep 2025

Journal name: Cell Rep Med

Gene context drift identifies drug targets to mitigate cancer treatment resistance.

Authors: A Jassim, BV Nimmervoll, S Terranova, E Nathan, L Hu, JT Taylor, KE Masih, ...

E-pub date: 8 Sep 2025

Journal name: Cancer Cell

In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.

Authors: CYC Lee, I Dean, N Richoz, Z Li, BC Kennedy, LA Vettore, Y Samarakoon, KL G...

E-pub date: 2 Sep 2025

Journal name: Cancer Immunol Res

Filters

Research Groups

Core Facilities

Start date

End date

WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance.

Artifacts in photoacoustic imaging: Origins and mitigations.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Coordinated protein modules define DNA damage responses to carboplatin at single-cell resolution in human ovarian carcinoma models.

Gene context drift identifies drug targets to mitigate cancer treatment resistance.

In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

WEE1 inhibitors synergise with mRNA translation defects via activation of the kinase GCN2.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Clinical decision tree for optimizing endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillance.

Artifacts in photoacoustic imaging: Origins and mitigations.

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Coordinated protein modules define DNA damage responses to carboplatin at single-cell resolution in human ovarian carcinoma models.

Gene context drift identifies drug targets to mitigate cancer treatment resistance.

In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.